159 related articles for article (PubMed ID: 38572510)
21. Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers.
Geldenhuys W; Wehrung D; Groshev A; Hirani A; Sutariya V
Pharm Dev Technol; 2015 Jun; 20(4):497-506. PubMed ID: 24597667
[TBL] [Abstract][Full Text] [Related]
22. Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier.
Gan CW; Feng SS
Biomaterials; 2010 Oct; 31(30):7748-57. PubMed ID: 20673685
[TBL] [Abstract][Full Text] [Related]
23. Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier.
Tosi G; Bortot B; Ruozi B; Dolcetta D; Vandelli MA; Forni F; Severini GM
Curr Med Chem; 2013; 20(17):2212-25. PubMed ID: 23458620
[TBL] [Abstract][Full Text] [Related]
24. Optimization of ionic liquid-incorporated PLGA nanoparticles for treatment of biofilm infections.
Takahashi C; Hattori Y; Yagi S; Murai T; Takai C; Ogawa N; Tanemura M; Fuji M; Kawashima Y; Yamamoto H
Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():78-83. PubMed ID: 30678968
[TBL] [Abstract][Full Text] [Related]
25. Nanoparticle enabled drug delivery across the blood brain barrier: in vivo and in vitro models, opportunities and challenges.
Gidwani M; Singh AV
Curr Pharm Biotechnol; 2014; 14(14):1201-12. PubMed ID: 24809717
[TBL] [Abstract][Full Text] [Related]
26. Biodegradable polymeric nanoparticles administered in the cerebrospinal fluid: Brain biodistribution, preferential internalization in microglia and implications for cell-selective drug release.
Peviani M; Capasso Palmiero U; Cecere F; Milazzo R; Moscatelli D; Biffi A
Biomaterials; 2019 Jul; 209():25-40. PubMed ID: 31026609
[TBL] [Abstract][Full Text] [Related]
27. L-Carnitine-conjugated nanoparticles to promote permeation across blood-brain barrier and to target glioma cells for drug delivery via the novel organic cation/carnitine transporter OCTN2.
Kou L; Hou Y; Yao Q; Guo W; Wang G; Wang M; Fu Q; He Z; Ganapathy V; Sun J
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1605-1616. PubMed ID: 28974108
[TBL] [Abstract][Full Text] [Related]
28. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
Zhao X; Ye Y; Ge S; Sun P; Yu P
Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
[TBL] [Abstract][Full Text] [Related]
29. Tailoring Lipid and Polymeric Nanoparticles as siRNA Carriers towards the Blood-Brain Barrier - from Targeting to Safe Administration.
Gomes MJ; Fernandes C; Martins S; Borges F; Sarmento B
J Neuroimmune Pharmacol; 2017 Mar; 12(1):107-119. PubMed ID: 27209050
[TBL] [Abstract][Full Text] [Related]
30. Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution.
Vergoni AV; Tosi G; Tacchi R; Vandelli MA; Bertolini A; Costantino L
Nanomedicine; 2009 Dec; 5(4):369-77. PubMed ID: 19341816
[TBL] [Abstract][Full Text] [Related]
31. Neural Cell Membrane-Coated Nanoparticles for Targeted and Enhanced Uptake by Central Nervous System Cells.
Zhang N; Lin J; Chew SY
ACS Appl Mater Interfaces; 2021 Dec; 13(47):55840-55850. PubMed ID: 34792341
[TBL] [Abstract][Full Text] [Related]
32. Polymeric nanoparticles for drug delivery to the central nervous system.
Patel T; Zhou J; Piepmeier JM; Saltzman WM
Adv Drug Deliv Rev; 2012 May; 64(7):701-5. PubMed ID: 22210134
[TBL] [Abstract][Full Text] [Related]
33. Development of L-carnosine functionalized iron oxide nanoparticles loaded with dexamethasone for simultaneous therapeutic potential of blood brain barrier crossing and ischemic stroke treatment.
Lu X; Zhang Y; Wang L; Li G; Gao J; Wang Y
Drug Deliv; 2021 Dec; 28(1):380-389. PubMed ID: 33586561
[TBL] [Abstract][Full Text] [Related]
34. PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood-brain barrier.
Fornaguera C; Dols-Perez A; Calderó G; García-Celma MJ; Camarasa J; Solans C
J Control Release; 2015 Aug; 211():134-43. PubMed ID: 26057857
[TBL] [Abstract][Full Text] [Related]
35. Cholesterol-PEG comodified poly (N-butyl) cyanoacrylate nanoparticles for brain delivery: in vitro and in vivo evaluations.
Hu X; Yang F; Liao Y; Li L; Zhang L
Drug Deliv; 2017 Nov; 24(1):121-132. PubMed ID: 28156159
[TBL] [Abstract][Full Text] [Related]
36. Combined Biomimetic MOF-RVG15 Nanoformulation Efficient Over BBB for Effective Anti-Glioblastoma in Mice Model.
Wu H; Liu Y; Chen L; Wang S; Liu C; Zhao H; Jin M; Chang S; Quan X; Cui M; Wan H; Gao Z; Huang W
Int J Nanomedicine; 2022; 17():6377-6398. PubMed ID: 36545220
[TBL] [Abstract][Full Text] [Related]
37. Nanocarriers for brain specific delivery of anti-retro viral drugs: challenges and achievements.
Varghese NM; Senthil V; Saxena SK
J Drug Target; 2018 Mar; 26(3):195-207. PubMed ID: 28866957
[TBL] [Abstract][Full Text] [Related]
38. Nanoformulated Antiretrovirals for Penetration of the Central Nervous System: State of the Art.
Fiandra L; Capetti A; Sorrentino L; Corsi F
J Neuroimmune Pharmacol; 2017 Mar; 12(1):17-30. PubMed ID: 27832401
[TBL] [Abstract][Full Text] [Related]
39. Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood-brain barrier.
Tosi G; Fano RA; Bondioli L; Badiali L; Benassi R; Rivasi F; Ruozi B; Forni F; Vandelli MA
Nanomedicine (Lond); 2011 Apr; 6(3):423-36. PubMed ID: 21542682
[TBL] [Abstract][Full Text] [Related]
40. Interaction of surfactant coated PLGA nanoparticles with in vitro human brain-like endothelial cells.
Moya ELJ; Lombardo SM; Vandenhaute E; Schneider M; Mysiorek C; Türeli AE; Kanda T; Shimizu F; Sano Y; Maubon N; Gosselet F; Günday-Türeli N; Dehouck MP
Int J Pharm; 2022 Jun; 621():121780. PubMed ID: 35504427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
